首页> 美国卫生研究院文献>Journal of Applied Clinical Medical Physics >Dosimetric comparison study between intensity modulated radiation therapy and three‐dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer
【2h】

Dosimetric comparison study between intensity modulated radiation therapy and three‐dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer

机译:调强放射疗法与三维共形质子疗法在盆腔骨髓保留治疗宫颈癌中的剂量学比较研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective was to compare intensity‐modulated radiation therapy (IMRT) with 3D conformal proton therapy (3DCPT) in the treatment of cervical cancer. In particular, each technique's ability to spare pelvic bone marrow (PBM) was of primary interest in this study. A total of six cervical cancer patients (3 postoperative and 3 intact) were planned and analyzed. All plans had uniform 1.0 cm CTV‐PTV margin and satisfied the 95% PTV with 100% isodose (prescription dose = 45 Gy) coverage. Dose‐volume histograms (DVH) were analyzed for comparison. The overall PTV and PBM volumes were 1035.9 ± 192.2 cc and 1151.4 ± 198.3 cc, respectively. In terms of PTV dose conformity index (DCI) and dose homogeneity index (DHI), 3DCPT was slightly superior to IMRT with 1.00 ± 0.001,  1.01 ± 0.02, and 1.10 ± 0.02,  1.13 ± 0.01, respectively. In addition, 3DCPT demonstrated superiority in reducing lower doses (i.e., V30 or less) to PBM, small bowel and bladder. Particularly in PBM, average V10 and V20 reductions of 10.8% and 7.4%(p = 0.001 and 0.04), respectively, were observed. However, in the higher dose range, IMRT provided better sparing (   V30). For example, in small bowel and PBM, average reductions in V45 of 4.9% and 10.0%(p = 0.048 and 0.008), respectively, were observed. Due to its physical characteristics such as low entrance dose, spread‐out Bragg peak and finite particle range of protons, 3DCPT illustrated superior target coverage uniformity and sparing of the lower doses in PBM and other organs. Further studies are, however, needed to fully exploit the benefits of protons for general use in cervical cancer.PACS number: 87.55.D‐, 87.55.dk
机译:目的是比较调强放射治疗(IMRT)与3D保形质子治疗(3DCPT)在宫颈癌的治疗中的作用。尤其是,这项技术中每种技术的骨盆骨髓(PBM)备用能力都是最主要的兴趣所在。计划和分析了总共6例宫颈癌患者(3例术后和3例完整)。所有计划均具有1.0 cm CTV-PTV的均匀余量,并满足95%PTV和100%的等剂量剂量(处方剂量= 45 Gy)。分析剂量-体积直方图(DVH)进行比较。 PTV和PBM的总体积分别为1035.9±192.2 cc和1151.4±198.3 cc。就PTV剂量一致性指数(DCI)和剂量均一性指数(DHI)而言,3DCPT分别略优于IMRT,分别为1.00±0.001、1.01±0.02和1.10±0.02、1.13±0.01。此外,3DCPT在减少PBM,小肠和膀胱的较低剂量(即V30或更低)方面显示出优势。特别是在PBM中,观察到平均V10和V20降低了10.8%和7.4%(p = 0.001和0.04)。但是,在较高剂量范围内,IMRT提供了更好的备用性(> V30)。例如,在小肠和PBM中,观察到V45的平均减少分别为4.9%和10.0%(p = 0.048和0.008)。由于3DCPT具有低入射剂量,散布的Bragg峰和质子有限的粒子范围等物理特性,因此可显示出优异的靶标覆盖范围均匀性,并且在PBM和其他器官中可保留较低剂量。但是,需要进一步研究以充分利用质子在宫颈癌中的通用性.PACS编号:87.55.D-,87.55.dk

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号